Zobrazeno 1 - 10
of 209
pro vyhledávání: '"Tibor, Szarvas"'
Autor:
Teemu J. Murtola, Aino Siltari, Paavo Raittinen, Teuvo L.J. Tammela, Stig Linder, Anita Csizmarik, Gero Kramer, Tibor Szarvas
Publikováno v:
European Urology Open Science, Vol 70, Iss , Pp 135-141 (2024)
Background and objective: Prostate-specific antigen (PSA) is of limited value as a surrogate marker for overall survival (OS) in prostate cancer (PC). Serum thymidine kinase 1 (sTK1) is an enzyme expressed by actively dividing cells. Our aim was to e
Externí odkaz:
https://doaj.org/article/f5f7b70d5e4c48bf8a57e54d730f0797
Autor:
Melinda Váradi, Orsolya Horváth, Orsolya Módos, Tamás Fazekas, Camilla M. Grunewald, Günter Niegisch, Ulrich Krafft, Viktor Grünwald, Boris Hadaschik, Csilla Olah, Anikó Maráz, Andrea Furka, Miklós Szűcs, Péter Nyirády, Tibor Szarvas
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Clinical trials revealed significant antitumor activity for immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC). Due to their strict eligibility criteria, clinical trials include selected patient cohorts, and thus do
Externí odkaz:
https://doaj.org/article/1a068853788840639a37f8acf3d9283b
Autor:
Florestan J. Koll, Claudia Döring, Csilla Olah, Tibor Szarvas, Jens Köllermann, Benedikt Hoeh, Felix K.-H. Chun, Henning Reis, Peter J. Wild
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Molecular subtypes predict prognosis in muscle-invasive bladder cancer (MIBC) and are explored as predictive markers. To provide a common base for molecular subtyping and facilitate clinical applications, a consensus classificatio
Externí odkaz:
https://doaj.org/article/be9abe9cb2c64dd1a0fe2694296bfac9
Autor:
Melinda Varadi, Nikolett Nagy, Henning Reis, Boris Hadaschik, Christian Niedworok, Orsolya Modos, Attila Szendroi, Jason Ablat, Peter C. Black, David Keresztes, Anita Csizmarik, Csilla Olah, Nadine T. Gaisa, Andras Kiss, Jozsef Timar, Erika Toth, Erzsebet Csernak, Arpad Gerstner, Vinay Mittal, Sofia Karkampouna, Marianna Kruithof de Julio, Balazs Gyorffy, Gabor Bedics, Michael Rink, Margit Fisch, Peter Nyirady, Tibor Szarvas
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 9041-9054 (2023)
Abstract Objective Administration of targeted therapies provides a promising treatment strategy for urachal adenocarcinoma (UrC) or primary bladder adenocarcinoma (PBAC); however, the selection of appropriate drugs remains difficult. Here, we aimed t
Externí odkaz:
https://doaj.org/article/e41fec3667254bd390a37fade443482d
Autor:
Abdel Jelil Njouendou, Tibor Szarvas, Arnol Auvaker Zebaze Tiofack, Rovaldo Nguims Kenfack, Pamela Derliche Tonouo, Sidonie Noa Ananga, Esther H. M. Dina Bell, Gustave Simo, Jörg D. Hoheisel, Jens T. Siveke, Smiths S. Lueong
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Background Inflammation is undoubtedly a hallmark of cancer development. Its maintenance within tumors and the consequences on disease aggressiveness are insufficiently understood. Methods Data of 27 tumor entities (about 5000 samples) were
Externí odkaz:
https://doaj.org/article/c4c04dc7508e4c02a1013c66e211ba35
Autor:
Csilla Olah, Henning Reis, Michèle J. Hoffmann, Fabian Mairinger, Saskia Ting, Boris Hadaschik, Ulrich Krafft, Viktor Grünwald, Peter Nyirady, Melinda Varadi, Balázs Győrffy, Andras Kiss, Eszter Szekely, Gottfrid Sjödahl, Tibor Szarvas
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 5222-5232 (2023)
Abstract Objective Although targeted approaches have become available in second‐ and third‐line settings, platinum‐based chemotherapy remains the standard first‐line treatment for advanced muscle‐invasive bladder cancer (MIBC). Therefore, t
Externí odkaz:
https://doaj.org/article/7547c69a833c47a98b4d560264ca3735
Autor:
Anett Szabó, Szilárd Váncsa, Péter Hegyi, Alex Váradi, Attila Forintos, Teodóra Filipov, Júlia Ács, Nándor Ács, Tibor Szarvas, Péter Nyirády, Zsolt Kopa
Publikováno v:
Reproductive Biology and Endocrinology, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Introduction Infertility affects one in every six couples in developed countries, and approximately 50% is of male origin. In 2021, sperm DNA fragmentation (SDF) testing became an evidence-based test for fertility evaluations depicting ferti
Externí odkaz:
https://doaj.org/article/390e85f4836c46e697a9d959ae82744c
Autor:
Zsófia Küronya, Georgina Fröhlich, Andrea Ladányi, Tamás Martin, Lajos Géczi, Fruzsina Gyergyai, Orsolya Horváth, Gergő Kiszner, Ágnes Kovács, Tamás Dienes, Enikő Lénárt, Krisztián Nagyiványi, Tibor Szarvas, Mihály Szőnyi, Attila Tóth, Krisztina Biró
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background In Hungary, the mortality rate for testicular germ cell cancer (TGCC) is 0,9/100000 which is significantly higher than the EU average. We prospectively evaluated the effect of socioeconomic position on patient delay and therapy ou
Externí odkaz:
https://doaj.org/article/71f2f09dcb1b4178be049798a5d57614
Autor:
András Kubik, Isabel Pinto Amorim das Virgens, Anett Szabó, Melinda Váradi, Anita Csizmarik, Attila Keszthelyi, Attila Majoros, Péter Fehérvári, Péter Hegyi, Nándor Ács, Péter Nyirády, Tibor Szarvas
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 9, p 7859 (2023)
Lymph node (LN) status is the most significant prognostic factor for invasive urothelial bladder cancer (UBC); however, the optimal extent of LN dissection (LND) is debated. We assessed circulating matrix metalloproteinase-7 (MMP-7) as a prognostic f
Externí odkaz:
https://doaj.org/article/896f2dda508b4d909d07b4f91ad3a9f2
Autor:
Tibor Szarvas, Henning Reis
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/84abc1cde8214150a5996c3cc3d02bc9